2022 annual financial data
Ensysce Biosciences 2022 Operating margin
Ensysce Biosciences 2022 operating margin with verified reported values.
Direct answer
Operating margin was -959.91%.
Operating income was -24,222,095 USD and net income was -24,961,561 USD.
Operating cash flow was -17,887,439 USD.
Get free Ensysce Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,523,380 USD
- Operating income
- -24,222,095 USD
- Net income
- -24,961,561 USD
- Operating cash flow
- -17,887,439 USD